The FDA declared the tirzepatide shortage resolved in December 2024 and the semaglutide shortage resolved in February 2025, then set deadlines after which compounders could no longer produce preparations that are essentially copies of the approved drugs: February 18 and March 19, 2025 for tirzepatide, and April 22 and May 22, 2025 for semaglutide, for 503A pharmacies and 503B outsourcing facilities respectively
Correlation between gut microbiota and glucagon-like peptide-1 in patients with gestational diabetes mellitus
We believe sustainable success is built on a foundation of safety and support
For the first 38 years of my life, I was overweight now Im six stone (38kg) [83 pounds] lighter, Tanya Hall, a Wegovy user who cant get off the drug, told the news organization
Bear in mind at this time, only 1% of African Americans in Mississippi graduated high school